Mukul Agrawal made a fresh entry & bought 11,00,000 shares of this hospital sector stock; FIIs & DIIs decrease stake QoQ

DSIJ Intelligence-1 / 20 Jul 2025/ Categories: Mindshare, Trending

Mukul Agrawal made a fresh entry & bought 11,00,000 shares of this hospital sector stock; FIIs & DIIs decrease stake QoQ

In FY25, the company reported net sales of Rs 880 crore and net profit of Rs 131 crore.

On Friday, the Indian stock market ended the day in red with the Sensex & Nifty-50 indices down 0.60 per cent each. Although the market was in the red, one stock from the Hospital sector was up 1.57 per cent to Rs 625.90 per share, with an intraday high of Rs 635.10 per share and an intraday low of Rs 613.25 per share. The stock’s 52-week high is Rs 629.85 per share and its 52-week low is Rs 345.35 per share.

In Q1FY26, ace investor Mukul Agrawal made a fresh entry by buying 11,00,000 shares, or a 1.14 per cent stake in the company. In Q1FY26, FIIs and DIIs decreased their stake to 4.34 per cent and 13.52 per cent, respectively, compared to Q4FY25.

The hospital sector stock in which Mukul Agrawal invested is Yatharth Hospital & Trauma Care Services Ltd

DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.

Yatharth Hospital & Trauma Care Services Ltd., established in 2008, is a prominent multi-care hospital chain with 7 hospitals across North India, predominantly in metro areas. Their portfolio includes facilities in Greater Noida (400 beds, 66 per cent occupancy), Noida (250 beds, 83 per cent occupancy), Noida Extension (450 beds, 60 per cent occupancy), Jhansi-Orchha (305 beds, 47 per cent occupancy), and Greater Faridabad (200 beds, ramping up at 28 per cent occupancy). These hospitals boast a significant number of ICU beds, indicating their focus on critical care services. The company recently announced the acquisition of a 300-bed facility in New Delhi and a ~400-bed facility in Sector 20, Faridabad, further expanding their total bed capacity to over 2,300 beds.

The company has a market capitalisation of over Rs 6,000 crore and has delivered a strong profit growth of 152 per cent CAGR over the last five years. The shares of the company have a PE of 46x, an ROE of 11 per cent and an ROCE of 14 per cent. In FY25, the company reported net sales of Rs 880 crore and net profit of Rs 131 crore. The stock is up over 80 per cent from its 52-week low of Rs 345.55 per share.

Disclaimer: The article is for informational purposes only and not investment advice.